Return to Medical Devices Alert Section
Research from Massachusetts General Hospital provides new data about annuloplasty
November 27th, 2007
2007 NOV 27 -- According to recent research from the United States, "Recurrent ischemic mitral regurgitation (IMR) is frequent despite initial reduction by annuloplasty because continued LV remodeling increases tethering to the infarcted papillary muscle (PM). We have previously shown that PM repositioning by an external patch device can acutely reduce IMR." "In this study, we tested the hypothesis that IMR reduction persists despite possible continued LV remodelingIn 7 sheep, we used a chronic ischemic posterior infarct model that produces LV dilatation and MR over 10 weeks. An epicardial patch device was adjusted under echo guidance to reduce MR, with follow- up over a further 8 weeks and evaluation by 3D echo and sonomicrometry. In all 7 sheep, moderate IMR resolved with acute patch application and PM repositioning (6.5 +/- 1.8 mm to 0.6 +/- 1.3 mm proximal jet width, P< 0.001) without decrease in LVEF (43 +/- 3% to 44 +/- 8%). Eight weeks after PM repositioning, MR was not significantly greater (0.6 +/- 1.3 mm versus (1.0 +/- 1.0 mm, P = NS) despite an increase in LV volumes in 3 animals (2 had increases of 50 +/- 15%). On average, LV volumes did not change significantly (ESV: 46 +/- 8 mL versus 49 +/- 15 mL; P = NS and EDV: 85 +/- 16 mL versus 89 +/- 30 mL; P = NS). LVEF was unchanged from acute to chronic patch (44 +/- 8% versus 43 +/- 8%). Contractility as end-systolic elastance did not decrease from the chronic MI to the acute and chronic patch stages, nor were there any significant changes in dP/dt, LV stiffness constant, or time constant of LV relaxation (Tau)PM repositioning is persistently effective in reducing moderate chronic IMR, even when LV volume increases," wrote J. Hung and colleagues, Massachusetts General Hospital. The researchers concluded: "This may reflect structural stabilization by an external patch device of the papillary muscle-LV wall complex that controls mitral valve tethering." Hung and colleagues published their study in Circulation (Persistent reduction of ischemic mitral regurgitation by papillary muscle repositioning - Structural stabilization of the papillary muscle-ventricular wall complex. Circulation, 2007;116(11 Suppl.):I259-I263). For additional information, contact J. Hung, Massachusetts General Hospital, Cardiac Ultrasound Laboratory, Blake 256, 55 Fruit St., Boston, MA 02114, USA. Publisher contact information for the journal Circulation is: Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA. Keywords: United States, Boston, Annuloplasty, Medical Device, Massachusetts General Hospital. This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2007, Life Science Weekly via NewsRx.com.
Return to Medical Devices Alert Section
|
